Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for - KGET.com

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com

ced pexels 6129204Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com” style=”width:100%;max-height:420px;object-fit:cover;border-radius:8px;display:block;” />
✦ New
CED Clinical Relevance
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
THCSafetyNeurologyMental HealthResearchDosingMedical
Why This Matters
Clinicians need to recognize cannabinoid hyperemesis syndrome (CHS) as a diagnosis of exclusion in patients with severe nausea and vomiting, since increased cannabis potency and frequency of use have made this condition more common in clinical settings. Understanding CHS presentation and reliably diagnosing it can prevent unnecessary invasive testing and lead to appropriate management through cannabis cessation rather than standard antiemetic protocols. Educating patients about this dose-dependent adverse effect is critical for informed decision-making about cannabis use, particularly as products with higher THC concentrations become more accessible.
Clinical Summary

Cannabinoid hyperemesis syndrome (CHS) is an increasingly recognized adverse effect characterized by cyclical nausea, vomiting, and compulsive hot bathing in chronic cannabis users, with incidence rising alongside increased potency and frequency of use. The syndrome typically presents in patients with long-term heavy cannabis consumption, particularly those using high-THC products, and manifests in a prodromal phase of mild nausea followed by hyperemetic episodes with severe vomiting that can lead to dehydration and electrolyte imbalances. Clinicians should maintain suspicion for CHS in patients presenting with intractable nausea and vomiting, especially those with a history of cannabis use who have failed conventional antiemetic therapy and report relief with cessation of use or hot water immersion. The rising prevalence of CHS is directly tied to modern cannabis products with elevated THC concentrations and increased accessibility, making this a growing concern in emergency departments and primary care settings where cannabis use is now legal in many jurisdictions. Recognition and diagnosis of CHS is critical because standard antiemetics are often ineffective, and the condition typically resolves only with cannabis cessation, making patient education and substance use counseling essential components of management. Clinicians encountering patients with severe, recurrent vomiting should specifically inquire about cannabis use patterns and consider CHS in the differential diagnosis to avoid unnecessary diagnostic testing and ineffective treatments.

Dr. Caplan’s Take
“Cannabinoid hyperemesis syndrome is a real clinical entity we’re seeing more frequently, and it’s almost always associated with high-potency daily cannabis use, so when a patient presents with intractable nausea and vomiting that paradoxically improves with hot showers, we need to ask detailed questions about consumption patterns rather than reflexively ordering imaging or considering surgical causes.”
Clinical Perspective

๐Ÿ’Š Cannabinoid hyperemesis syndrome (CHS) represents an emerging clinical challenge as cannabis use becomes increasingly normalized and potent products proliferate, yet the syndrome remains underrecognized among frontline providers. Patients typically present with severe, cyclical nausea and vomiting refractory to standard antiemetics, often with a pathognomonic pattern of temporary relief from hot showersโ€”a presentation that can mimic gastroenterological or neurological disorders and lead to unnecessary workup and delayed diagnosis. The exact pathophysiological mechanism remains incompletely understood, which complicates both counseling about risk factors and discussions regarding individual susceptibility. Given that cessation of cannabis use is the only definitive treatment, clinicians should maintain clinical suspicion for CHS in patients with recurrent unexplained vomiting and regular cannabis use, particularly those using high-potency products or concentrates. A targeted history exploring cannabis consumption

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance